US Map / North Carolina
State NC

Clinical Trials in North Carolina

North Carolina is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in North Carolina and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 420 actively recruiting studies with North Carolina sites out of 420 registered in total. The busiest research areas in North Carolina are Breast Cancer, Acute Myeloid Leukemia, Cancer. Leading sponsors running trials in the state include Duke University, Wake Forest University Health Sciences, National Cancer Institute (NCI). By stage, North Carolina trials break down as Phase 1 (67), Phase 2 (115), Phase 3 (110), Phase 4 (20).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
420
Recruiting Now
420
← Back to US Map
Top Conditions in North Carolina
Breast Cancer (11)Acute Myeloid Leukemia (6)Cancer (6)Solid Tumor (6)Obesity (6)Heart Failure (6)Multiple Myeloma (6)Pancreatic Cancer (4)Systemic Lupus Erythematosus (4)Atopic Dermatitis (4)Coronary Artery Disease (4)Overweight (4)

Frequently Asked Questions — Clinical Trials in North Carolina

How many clinical trials are currently recruiting in North Carolina?
ClinicalMetric currently tracks 420 actively recruiting clinical trials with at least one location in North Carolina. The total number of registered studies—including active but not currently enrolling trials—is 420. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in North Carolina?
North Carolina hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Acute Myeloid Leukemia, Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout North Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in North Carolina?
To join a clinical trial in North Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in North Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in North Carolina

NCT05058651 Phase 2, Phase 3
Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemo...
Condition
Advanced Extrapulmonary Neuroendocrine Carcinoma
Enrollment
189 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT00271180 N/A
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medt...
Condition
Arrhythmia
Enrollment
20,000 pts
Location
United States, Australia, Austria
Sponsor
Medtronic
View Trial →
NCT05766670 Phase 3
Recruiting
Intramedullary Calcium Sulfate Antibiotic Depot
Condition
Open tíbia Fracture
Enrollment
242 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT05431088 Phase 2, Phase 3
Recruiting
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Condition
Sickle Cell Disease
Enrollment
389 pts
Location
United States, Brazil, India
Sponsor
Pfizer
View Trial →
NCT07784270 Phase 3
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes...
Condition
Obesity or Overweight
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT06328127 N/A
Recruiting
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Sur...
Condition
Hematopoietic Stem Cell Transplant
Enrollment
400 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT05563766 Phase 2
Recruiting
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete R...
Condition
Esophageal Adenocarcinoma
Enrollment
78 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT07664553 Phase 3
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compare...
Condition
Type 2 Diabetes Mellitus
Enrollment
600 pts
Location
United States, Australia, Bulgaria
Sponsor
AstraZeneca
View Trial →
NCT07110337 N/A
Recruiting
Diagnosing Epilepsy To EffeCT Change
Condition
Epilepsy
Enrollment
210 pts
Location
United States
Sponsor
Epiminder America, Inc.
View Trial →
NCT07264270 Phase 1
Recruiting
Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic ...
Condition
Lumbosacral Radicular Pain
Enrollment
24 pts
Location
United States, Australia
Sponsor
Consano Bio
View Trial →
NCT06638502 Phase 1, Phase 2
Recruiting
Safety of HRX215 in Patients After Minor and Major Liver Resection
Condition
Liver Resection
Enrollment
80 pts
Location
United States, France, Germany
Sponsor
HepaRegeniX GmbH
View Trial →
NCT07013474 Phase 3
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 W...
Condition
COVID-19 Infection
Enrollment
300 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
View Trial →
NCT05150691 Phase 1, Phase 2
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Condition
HER2-positive Advanced Solid Tumor
Enrollment
796 pts
Location
United States, Australia, China
Sponsor
DualityBio Inc.
View Trial →
NCT05667142 Phase 3
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-C...
Condition
Primary Generalized Tonic-Clonic Seizures
Enrollment
160 pts
Location
United States, Argentina, Australia
Sponsor
Xenon Pharmaceuticals Inc.
View Trial →
NCT07867080 Phase 3
Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Mac...
Condition
Diabetic Macular Edema (DME)
Enrollment
514 pts
Location
United States, China, Japan
Sponsor
4D Molecular Therapeutics
View Trial →
NCT00567073 N/A
Recruiting
Pompe Pregnancy Sub-Registry
Condition
Glycogen Storage Disease Type II (GSD-II)
Enrollment
20 pts
Location
United States, Australia, Belgium
Sponsor
Genzyme, a Sanofi Company
View Trial →
NCT06049680 Phase 4
Recruiting
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in...
Condition
Malnutrition, Child
Enrollment
100 pts
Location
United States
Sponsor
Fresenius Kabi
View Trial →
NCT07243652 N/A
Recruiting
I-DECIDE After Bronchiolitis Hospitalization
Condition
Bronchiolitis Acute
Enrollment
2,700 pts
Location
United States, Canada
Sponsor
Seattle Children's Hospital
View Trial →
NCT04715178 N/A
Recruiting
Beat Childhood Cancer Specimen Banking and Data Registry
Condition
Pediatric Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
Giselle Sholler
View Trial →
NCT07723248 Phase 3
Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Pati...
Condition
Metastatic Castration Resistant Prostate Cancer
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
ORIC Pharmaceuticals
View Trial →
NCT06801535 N/A
Recruiting
Efficacy of 3D-Printed Mouth Splints
Condition
Microstomia
Enrollment
10 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT04298255 N/A
Recruiting
Experimental Round Spermatid Injection (ROSI) to Treat Infertile Couples
Condition
Infertility, Male
Enrollment
50 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT06896474 N/A
Recruiting
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk...
Condition
Breast Cancer
Enrollment
402 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical
View Trial →
NCT04561518 N/A
Recruiting
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-M...
Condition
Transthyretin-Mediated Amyloidosis
Enrollment
1,500 pts
Location
United States, Brazil, Bulgaria
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT07428538 Phase 3
Recruiting
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With ...
Condition
Hepatitis
Enrollment
350 pts
Location
United States
Sponsor
Bausch Health Americas, Inc.
View Trial →
Page 11 of 17 — 420 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology